WallStreetZenWallStreetZen

NASDAQ: APLT
Applied Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for APLT

Based on 1 analyst offering 12 month price targets for Applied Therapeutics Inc

Min Forecast
$1.00+986.96%
Avg Forecast
$1.00+986.96%
Max Forecast
$1.00+986.96%

Should I buy or sell APLT stock?

Based on 1 analyst offering ratings for Applied Therapeutics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APLT stock forecasts and price targets.

APLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-03

1 of 1

Forecast return on equity

Is APLT forecast to generate an efficient return?

Forecast return on assets

Is APLT forecast to generate an efficient return on assets?

Company
-29.97%
Industry
120.28%
APLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

APLT earnings per share forecast

What is APLT's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.44
Avg 2 year Forecast
-$0.22
Avg 3 year Forecast
-$0.22

APLT revenue forecast

What is APLT's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$1.3M+27.5%
Avg 2 year Forecast
$56.7M+5,568.7%
Avg 3 year Forecast
$66.6M+6,557.2%
APLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APLT revenue growth forecast

How is APLT forecast to perform vs Biotechnology companies and vs the US market?

Company
327.71%
Industry
116.73%
Market
23.58%
APLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APLT$0.09$1.00+986.96%Hold
TPST$2.94$11.00+274.15%Buy
SNGX$1.34N/AN/A
BOLT$7.09$7.00-1.27%Buy
QNRX$9.44N/AN/A
View Top Biotech Stocks

Applied Therapeutics Stock Forecast FAQ

Is Applied Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: APLT) stock is to Hold APLT stock.

Out of 1 analyst, 0 (0%) are recommending APLT as a Strong Buy, 0 (0%) are recommending APLT as a Buy, 1 (100%) are recommending APLT as a Hold, 0 (0%) are recommending APLT as a Sell, and 0 (0%) are recommending APLT as a Strong Sell.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.

What is APLT's earnings growth forecast for 2026-2028?

(NASDAQ: APLT) Applied Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.67%.

Applied Therapeutics's earnings in 2026 is -$18,138,000.On average, 6 Wall Street analysts forecast APLT's earnings for 2026 to be -$62,929,524, with the lowest APLT earnings forecast at -$72,121,477, and the highest APLT earnings forecast at -$43,939,555. On average, 5 Wall Street analysts forecast APLT's earnings for 2027 to be -$32,381,071, with the lowest APLT earnings forecast at -$42,424,398, and the highest APLT earnings forecast at -$13,636,414.

In 2028, APLT is forecast to generate -$32,381,071 in earnings, with the lowest earnings forecast at -$31,111,225 and the highest earnings forecast at -$33,333,456.

What is APLT's revenue growth forecast for 2026-2028?

(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of 327.71% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.58%.

Applied Therapeutics's revenue in 2026 is $1,000,000.On average, 6 Wall Street analysts forecast APLT's revenue for 2026 to be $183,983,359, with the lowest APLT revenue forecast at $0, and the highest APLT revenue forecast at $757,578,539. On average, 5 Wall Street analysts forecast APLT's revenue for 2027 to be $8,179,972,307, with the lowest APLT revenue forecast at $1,054,405,025, and the highest APLT revenue forecast at $13,844,062,363.

In 2028, APLT is forecast to generate $9,606,384,470 in revenue, with the lowest revenue forecast at $9,229,759,710 and the highest revenue forecast at $9,888,925,189.

What is APLT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: APLT) forecast ROA is -29.97%, which is lower than the forecast US Biotechnology industry average of 120.28%.

What is APLT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year APLT price target, the average APLT price target is $1.00, with the highest APLT stock price forecast at $1.00 and the lowest APLT stock price forecast at $1.00.

The Wall Street analyst predicted that Applied Therapeutics's share price could reach $1.00 by Dec 3, 2026. The average Applied Therapeutics stock price prediction forecasts a potential upside of 986.96% from the current APLT share price of $0.09.

What is APLT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: APLT) Applied Therapeutics's current Earnings Per Share (EPS) is -$0.10. On average, analysts forecast that APLT's EPS will be -$0.44 for 2026, with the lowest EPS forecast at -$0.50, and the highest EPS forecast at -$0.30. On average, analysts forecast that APLT's EPS will be -$0.22 for 2027, with the lowest EPS forecast at -$0.29, and the highest EPS forecast at -$0.09. In 2028, APLT's EPS is forecast to hit -$0.22 (min: -$0.22, max: -$0.23).

What is APLT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: APLT) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.